Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Dauntless who wrote (794)	11/18/1997 4:53:00 PM
From: Bradpalm1	Read Replies (1) \| Respond to of 7041

Dauntless, Careful reading is a skill. I SAID that I was reposting comments made by a urologist who claimed to be a Phase III investigator for Vasomax from the Zonagen board on Motley Fool/AOL (ZONA/MF), NOT from the SI board. I'm not this investigator (named ppmd4) and I don't refer to myself in the third person. I DID, however, give him credit for initially bringing attention to the major discrepancies and problems rumored about Vasomax' Phase II & III clinical trials. As I said, HE apparently was right all along (as were Cruttendon Roth and Genesis Merchant). Bradpalm1